These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10443637)

  • 21. Determining the potency of neuromuscular blockers: are traditional methods flawed?
    Kopman AF; Lien CA; Naguib M
    Br J Anaesth; 2010 Jun; 104(6):705-10. PubMed ID: 20430764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative study of the dose-response and time course of recovery of atracurium and rocuronium.
    Xue F; Zhang Y; Liao X; Liu J; An G
    Chin Med J (Engl); 2000 Nov; 113(11):1019-21. PubMed ID: 11776116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cisatracurium or rocuronium versus rocuronium-cisatracurium combination.
    Zeidan A; Nahle N; Maaliki H; Baraka A
    Middle East J Anaesthesiol; 2006 Jun; 18(5):879-86. PubMed ID: 17094524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Augmentation of the neuromuscular blocking effects of cisatracurium during desflurane, sevoflurane, isoflurane or total i.v. anaesthesia.
    Wulf H; Kahl M; Ledowski T
    Br J Anaesth; 1998 Mar; 80(3):308-12. PubMed ID: 9623429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of neuromuscular block of atracurium and rocuronium in adults.
    Hans P; Brichant JF; Franzen A; Faleres X; Lamy M
    Acta Anaesthesiol Belg; 1996; 47(2):53-8. PubMed ID: 8869671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Duration of neuromuscular block is more variable and recovery time is shorter with rocuronium than cisatracurium in anesthetized dogs.
    Martin-Flores M; Hackman MC; Araos JD; Campoy L; Gleed RD
    Vet Ophthalmol; 2023 Sep; 26(5):407-413. PubMed ID: 36799561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo neuromuscular effects of atracurium and rocuronium in rats treated with carbamazepine for seven days.
    de Barcelos CC; Braga Ade F; Braga FS; Potério GB; Fernandes SC; Franco YO; Simioni LR
    Rev Bras Anestesiol; 2008; 58(2):137-51. PubMed ID: 19378532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased sensitivity to rocuronium and atracurium in mitochondrial myopathy.
    Finsterer J; Stratil U; Bittner R; Sporn P
    Can J Anaesth; 1998 Aug; 45(8):781-4. PubMed ID: 9793668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of cisatracurium and rocuronium on cisatracurium precurarization and the priming principle.
    Mak PH; Irwin MG
    J Clin Anesth; 2004 Mar; 16(2):83-7. PubMed ID: 15110367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ephedrine shortens the onset of action of rocuronium but not atracurium].
    Santiveri X; Mansilla R; Pardina B; Navarro J; Alvarez JC; Castillo J
    Rev Esp Anestesiol Reanim; 2003 Apr; 50(4):176-81. PubMed ID: 12825305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in myorelaxant therapy.
    Meakin GH
    Paediatr Anaesth; 2001; 11(5):523-31. PubMed ID: 11696115
    [No Abstract]   [Full Text] [Related]  

  • 32. The cerebral and cardiovascular effects of cisatracurium and atracurium in neurosurgical patients.
    Schramm WM; Papousek A; Michalek-Sauberer A; Czech T; Illievich U
    Anesth Analg; 1998 Jan; 86(1):123-7. PubMed ID: 9428865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility of intraoperative neuromonitoring during thyroid surgery after administration of nondepolarizing neuromuscular blocking agents.
    Chu KS; Wu SH; Lu IC; Tsai CJ; Wu CW; Kuo WR; Lee KW; Chiang FY
    World J Surg; 2009 Jul; 33(7):1408-13. PubMed ID: 19430831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodynamic effects of atracurium and cisatracurium and the use of diphenhydramine and cimetidine.
    Correa CM; Sudo GZ; Sudo RT
    Rev Bras Anestesiol; 2010; 60(1):52-63. PubMed ID: 20169263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atracurium, cisatracurium, vecuronium and rocuronium in patients with renal failure.
    Della Rocca G; Pompei L; Coccia C; Costa MG; Cecchini V; Vilardi V; Pietropaoli P
    Minerva Anestesiol; 2003; 69(7-8):605-11, 612, 5. PubMed ID: 14564242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Weal and flare responses to intradermal rocuronium and cisatracurium in humans.
    Levy JH; Gottge M; Szlam F; Zaffer R; McCall C
    Br J Anaesth; 2000 Dec; 85(6):844-9. PubMed ID: 11732517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
    Flockton EA; Mastronardi P; Hunter JM; Gomar C; Mirakhur RK; Aguilera L; Giunta FG; Meistelman C; Prins ME
    Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Site selectivity of competitive antagonists for the mouse adult muscle nicotinic acetylcholine receptor.
    Liu M; Dilger JP
    Mol Pharmacol; 2009 Jan; 75(1):166-73. PubMed ID: 18842832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of cisatracurium and rocuronium on lung function in anesthetized children.
    Yang CI; Fine GF; Jooste EH; Mutich R; Walczak SA; Motoyama EK
    Anesth Analg; 2013 Dec; 117(6):1393-400. PubMed ID: 24257390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nondepolarizing neuromuscular blocking drugs in the intensive care unit: a clinical review.
    Reeves ST; Turcasso NM
    South Med J; 1997 Aug; 90(8):769-74. PubMed ID: 9258301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.